Guido Steiner

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Clinical MAPPs: a personalized healthcare-driven assay for the direct identification of potential T cell epitopes in patients.

Clinical MAPPs: a personalized healthcare-driven assay for the direct identification of potential T cell epitopes in patients.

Journal: Frontiers in immunology
Published: May 12, 2026

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Journal: Clinical pharmacology and therapeutics
Published: March 07, 2026

Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer.

Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 23, 2025

Ocular Kinetics, Distribution, and Effects of Human VEGF Isoforms 121 and 165: Implications for Therapeutic Intervention.

Ocular Kinetics, Distribution, and Effects of Human VEGF Isoforms 121 and 165: Implications for Therapeutic Intervention.

Journal: Molecular pharmaceutics
Published: July 30, 2025

Elucidation of B-cell specific drug immunogenicity liabilities via a novel ex vivo assay.

Elucidation of B-cell specific drug immunogenicity liabilities via a novel ex vivo assay.

Journal: Frontiers in immunology
Published: March 07, 2025

Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release.

Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release.

Journal: Molecular therapy. Methods & clinical development
Published: December 13, 2024

Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy.

Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy.

Journal: Scientific reports
Published: June 11, 2024

Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti-PD-1.

Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti-PD-1.

Journal: ImmunoHorizons
Published: November 20, 2023

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.

Journal: Biology
Published: August 27, 2023

Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice.

Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice.

Journal: mAbs
Published: November 17, 2022

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.

Journal: Pharmaceutics
Published: October 31, 2022

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B.

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B.

Journal: Frontiers in immunology
Published: February 25, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026